Terns Pharmaceuticals Inc (TERN)
5.44
+0.15
(+2.84%)
USD |
NASDAQ |
May 03, 16:00
5.435
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Net Income (TTM): -90.21M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -90.21M |
| September 30, 2023 | -85.01M |
| June 30, 2023 | -72.07M |
| March 31, 2023 | -68.10M |
| December 31, 2022 | -60.34M |
| September 30, 2022 | -58.77M |
| June 30, 2022 | -53.79M |
| Date | Value |
|---|---|
| March 31, 2022 | -50.59M |
| December 31, 2021 | -50.16M |
| September 30, 2021 | -45.84M |
| June 30, 2021 | -45.44M |
| March 31, 2021 | -44.39M |
| December 31, 2020 | -40.05M |
| September 30, 2020 | -39.90M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-90.21M
Minimum
Dec 2023
-39.90M
Maximum
Sep 2020
-57.48M
Average
-52.19M
Median
Net Income (TTM) Benchmarks
| Viking Therapeutics Inc | -93.72M |
| Eli Lilly and Co | 6.138B |
| Pfizer Inc | -309.00M |
| Amgen Inc | 3.763B |
| Madrigal Pharmaceuticals Inc | -373.63M |